{"entity":{"type":"insider","cik":"0001451805","url":"/insider/0001451805","json_url":"/insider/0001451805.json","name":"Amello Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2010-05-26","last":"2022-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Amello Jason","source":"filing","n_filings":7,"first_seen":"2010-05-26","last_seen":"2022-12-12"}],"transactions":[{"id":6895145,"accession":"0001209191-22-060691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060691","line_url":"/filing/0001209191-22-060691#line-2","is_derivative":false,"issuer_cik":"0001451805","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001451805","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2468.0,"shares_display":"2,468","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":4763.24,"total_display":"4,763.24","total_whole":"4,763","shares_owned_after":5568.0,"shares_owned_after_display":"5,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-12","scope":"insider"},{"id":6895141,"accession":"0001209191-22-060691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-060691","line_url":"/filing/0001209191-22-060691#line-1","is_derivative":false,"issuer_cik":"0001451805","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001451805","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":5239.0,"total_display":"5,239.00","total_whole":"5,239","shares_owned_after":3100.0,"shares_owned_after_display":"3,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-12","scope":"insider"},{"id":2498934,"accession":"0001562180-20-001935","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-001935","line_url":"/filing/0001562180-20-001935#line-2","is_derivative":false,"issuer_cik":"0001451805","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001451805","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6976.0,"shares_display":"6,976","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":60691.2,"total_display":"60,691.20","total_whole":"60,691","shares_owned_after":144642.0,"shares_owned_after_display":"144,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-28","filed_date":"2020-03-02","scope":"insider"},{"id":6532383,"accession":"0001209191-14-071710","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-071710","line_url":"/filing/0001209191-14-071710#line-1","is_derivative":false,"issuer_cik":"0001451805","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001451805","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":13.22,"price_display":"13.22","price_state":"stated","total_value":13220.0,"total_display":"13,220.00","total_whole":"13,220","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-12-01","scope":"insider"},{"id":6971165,"accession":"0001209191-14-023435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-023435","line_url":"/filing/0001209191-14-023435#line-1","is_derivative":false,"issuer_cik":"0001451805","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001451805","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":68000.0,"total_display":"68,000.00","total_whole":"68,000","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-27","scope":"insider"},{"id":7368945,"accession":"0001223203-10-000207","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223203-10-000207","line_url":"/filing/0001223203-10-000207#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (Corp Contrllr,ChiefAccntOfficr)","role_mark":"O","role_mark_label":"Officer (Corp Contrllr,ChiefAccntOfficr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corp Contrllr,ChiefAccntOfficr","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6640.0,"shares_display":"6,640","price_per_share":70.3,"price_display":"70.30","price_state":"stated","total_value":466792.0,"total_display":"466,792.00","total_whole":"466,792","shares_owned_after":3270.0,"shares_owned_after_display":"3,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-31","filed_date":"2010-09-02","scope":"insider"},{"id":9002174,"accession":"0001225208-11-005262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-11-005262","line_url":"/filing/0001225208-11-005262#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (CorpContrllr,ChiefAccntOfficer)","role_mark":"O","role_mark_label":"Officer (CorpContrllr,ChiefAccntOfficer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CorpContrllr,ChiefAccntOfficer","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1042.0,"shares_display":"1,042","price_per_share":65.25,"price_display":"65.25","price_state":"stated","total_value":67990.5,"total_display":"67,990.50","total_whole":"67,991","shares_owned_after":1633.0,"shares_owned_after_display":"1,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-26","filed_date":"2011-02-10","scope":"insider"},{"id":9002173,"accession":"0001225208-11-005262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-11-005262","line_url":"/filing/0001225208-11-005262#line-1","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (CorpContrllr,ChiefAccntOfficer)","role_mark":"O","role_mark_label":"Officer (CorpContrllr,ChiefAccntOfficer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CorpContrllr,ChiefAccntOfficer","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595.0,"shares_display":"595","price_per_share":62.95,"price_display":"62.95","price_state":"stated","total_value":37455.25,"total_display":"37,455.25","total_whole":"37,455","shares_owned_after":2675.0,"shares_owned_after_display":"2,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-23","filed_date":"2011-02-10","scope":"insider"},{"id":7568204,"accession":"0001225208-10-013997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-013997","line_url":"/filing/0001225208-10-013997#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001451805","owner_name":"Amello Jason","owner_display_name":"Amello Jason","owner_url":"/insider/0001451805","role":"Officer (CorpContrllr,ChiefAccntOfficer)","role_mark":"O","role_mark_label":"Officer (CorpContrllr,ChiefAccntOfficer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CorpContrllr,ChiefAccntOfficer","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":533.0,"shares_display":"533","price_per_share":45.62,"price_display":"45.62","price_state":"stated","total_value":24315.46,"total_display":"24,315.46","total_whole":"24,315","shares_owned_after":3270.0,"shares_owned_after_display":"3,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-25","filed_date":"2010-05-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001841387","name":"Candel Therapeutics, Inc.","url":"/issuer/0001841387","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2022-12-12","last_seen":"2022-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Officer (SVP, CFO & Treasurer)","n_filings":3,"first_seen":"2014-03-27","last_seen":"2020-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000732485","name":"GENZYME CORP","url":"/issuer/0000732485","role":"Officer (CorpContrllr,ChiefAccntOfficer)","n_filings":3,"first_seen":"2010-05-26","last_seen":"2011-02-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001451805","retrieved_at":"2026-08-24T14:05:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}